Predictive factors for work‐day loss in Behçet's syndrome: A multi‐center study

Objective The aim of this multi‐center study was to assess predictive factors for work‐day loss as an indirect cost element in Behçet's syndrome (BS). Methods In this cross‐sectional, multi‐center study, 834 BS patients (F/M: 441/393, age mean: 38.4 ± 10.9 years) were included. Data were collec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of rheumatic diseases 2020-02, Vol.23 (2), p.240-246
Hauptverfasser: Mumcu, Gonca, Yay, Meral, Aksoy, Aysun, Taş, Mehmet Nedim, Armağan, Berkan, Sarı, Alper, Bozca, Burçin Cansu, Tekgöz, Emre, Karadağ, Duygu Temiz, Badak, Suade Özlem, Tecer, Duygu, Bes, Cemal, Şahin, Ali, Erken, Eren, Cefle, Ayse, Çınar, Muhammet, Yılmaz, Sedat, Karaçaylı, Ümit, Alpsoy, Erkan, Şenel, Soner, Yaşar Bilge, Şule, Kaşifoğlu, Timuçin, Karadağ, Ömer, Aksu, Kenan, Keser, Gökhan, Alibaz‐Öner, Fatma, İnanç, Nevsun, Ergun, Tülin, Direskeneli, Haner
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective The aim of this multi‐center study was to assess predictive factors for work‐day loss as an indirect cost element in Behçet's syndrome (BS). Methods In this cross‐sectional, multi‐center study, 834 BS patients (F/M: 441/393, age mean: 38.4 ± 10.9 years) were included. Data were collected by a questionnaire regarding treatment protocols, disease duration, smoking pattern, frequency of medical visits during the previous year and self‐reported work‐day loss during the previous year. Results Work‐day loss was observed in 16.2% of patients (M/F: 103/32). The percentages of being a smoker (81.8%), using immunosuppressive (IS) medications (82%), and having disease duration
ISSN:1756-1841
1756-185X
DOI:10.1111/1756-185X.13771